DBEF - ETF AI Analysis
Top Page
Xtrackers MSCI EAFE Hedged Equity ETF (DBEF)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Overall Performance
The ETF has shown strong gains so far this year and solid recent momentum, which suggests its strategy has been working well in the current market.
Leading Global Companies in Top Holdings
Several of the largest positions, such as ASML, HSBC, BHP, and other major multinationals, have delivered strong year-to-date results, helping drive the fund’s performance.
Broad International Diversification with Currency Hedge
The fund spreads its investments across many developed markets like Japan, the UK, Europe, and Australia while hedging currency exposure, which helps reduce the impact of foreign exchange swings on returns.
Negative Factors
Moderate Fee Level
The expense ratio is not extremely high but is also not among the very cheapest, meaning a modest portion of returns goes to fees each year.
Country Concentration in Japan and the UK
A large share of assets is invested in Japan and the UK, so weakness in these markets could have a noticeable impact on the ETF’s performance.
Some Lagging Top Holdings
AstraZeneca and a few other major positions have shown weaker or only modest performance, which can partially offset gains from stronger stocks in the portfolio.
DBEF vs. SPDR S&P 500 ETF (SPY)
AUM9.24B
RegionDeveloped Markets
Expense Ratio0.35%
Beta0.68
IssuerXtrackers
Inception DateJun 09, 2011
Dividend Yield4.84%
Asset ClassEquity
Index TrackedMSCI EAFE 100% Hedged to USD Net Variant
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume472,863
30 Day Avg. Volume429,707
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
64.87Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering655
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DBEF Summary
DBEF is an exchange-traded fund that follows the MSCI EAFE index, focusing on large and mid-sized companies in developed markets outside North America, such as Japan, the UK, and Europe. It owns many well-known international names like Nestlé and HSBC and spreads your money across sectors including financials, industrials, and health care. A key feature is that it hedges foreign currencies back to U.S. dollars, aiming to reduce the impact of exchange rate swings. Investors might consider DBEF for broad international diversification, but should remember that its stock prices can still go up and down with global markets.
How much will it cost me?The Xtrackers MSCI EAFE Hedged Equity ETF (DBEF) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it includes a currency hedging strategy to reduce the impact of exchange rate fluctuations. This added feature makes it a bit more expensive but can be valuable for international investors seeking stability.
What would affect this ETF?The DBEF ETF could benefit from economic growth in developed markets outside North America, particularly in Europe and Asia, as well as strong performance in sectors like financials and industrials, which make up a significant portion of its holdings. However, it may face challenges from global economic slowdowns, regulatory changes in key regions, or sector-specific risks such as fluctuating energy prices impacting companies like Shell. Additionally, while its currency hedging strategy helps mitigate exchange rate risks, unexpected shifts in currency policies or geopolitical tensions could still impact overall returns.
DBEF Top 10 Holdings
DBEF is leaning heavily on global blue chips, with ASML acting as the main engine thanks to its strong year-to-date run in semiconductors, even if recent momentum has been a bit mixed. Financials like HSBC and Mitsubishi UFJ are quietly supporting returns, while industrial heavyweight Siemens adds steady ballast. On the flip side, consumer giant Nestlé and pharma name AstraZeneca have been lagging, slightly dragging on performance. The fund is broadly diversified across sectors and anchored in developed markets outside North America, giving investors a global flavor without currency whiplash.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.08% | $280.57M | €581.61B | 86.21% | 76 Outperform | |
| HSBC Holdings | 1.57% | $142.80M | £259.22B | 45.81% | 80 Outperform | |
| Roche Holding AG | 1.36% | $124.00M | $346.33B | 37.61% | 73 Outperform | |
| Shell (UK) | 1.27% | $115.99M | £206.26B | 35.55% | 73 Outperform | |
| Novartis AG | 1.21% | $110.53M | CHF219.30B | 22.56% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 1.15% | $104.41M | ¥41.53T | 40.32% | 76 Outperform | |
| AstraZeneca | 1.14% | $103.57M | $257.92B | 12.66% | 80 Outperform | |
| Nestlé SA | 1.08% | $98.67M | CHF198.50B | 0.76% | 71 Outperform | |
| Siemens | 1.04% | $95.08M | €212.14B | 22.94% | 74 Outperform | |
| BHP Group Ltd | 0.97% | $88.16M | AU$308.67B | 50.00% | 68 Neutral |
DBEF Technical Analysis
Negative
―
Price Trends
55.46
Negative
54.50
Positive
52.31
Positive
Market Momentum
-0.08
Negative
45.71
Neutral
40.86
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DBEF, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 55.18, equal to the 50-day MA of 55.46, and equal to the 200-day MA of 52.31, indicating a neutral trend. The MACD of -0.08 indicates Negative momentum. The RSI at 45.71 is Neutral, neither overbought nor oversold. The STOCH value of 40.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DBEF.
DBEF Peer Comparison
Comparison Results
Performance Comparison
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
54.95
9.40
20.64%
BBIN
JPMorgan BetaBuilders International Equity ETF
―
―
―
EFAV
iShares MSCI EAFE Min Vol Factor ETF
―
―
―
HFXI
IQ 50 Percent Hedged FTSE International ETF
―
―
―
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
―
―
―
DDWM
WisdomTree Dynamic Currency Hedged International Equity Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents